Sarcopenic obesity with metabolic syndrome: A newly recognized entity following living donor liver transplantation

Clinical Transplantation

Volumn 29, Issue 3, 2015, Pages 211-215

  Choudhary, Narendra S ^a   Saigal, Sanjiv ^a   Saraf, Neeraj ^a   Mohanka, Ravi ^a   Rastogi, Amit ^a   Goja, Sanjay ^a   Menon, Palat B ^a   Mishra, Sunil ^a   Mittal, Ambrish ^a   Soin, Arvinder S ^a  

^a MEDANTA THE MEDICITY   (India)

Author keywords

Diabetes; Liver transplantation; Metabolic syndrome; Obesity; Sarcopenia

Indexed keywords

ALCOHOL; CYCLOSPORIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MYCOPHENOLIC ACID; STEROID; TACROLIMUS; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BODY COMPOSITION; CLINICAL TRIAL; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS C; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LIPOPROTEIN BLOOD LEVEL; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; SARCOPENIA; SARCOPENIC OBESITY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; COHORT ANALYSIS; MIDDLE AGED; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RISK FACTOR;

ADULT; AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; PREVALENCE; RISK FACTORS; SARCOPENIA;

EID: 84925280636     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12505     Document Type: Article

References (34)

1. Kassi E, Pervanidou P, Kaltasa G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med 2011: 9: 48.
2. Choudhary NS, Duseja A, Kalra N, Das A, Dhiman RK, Chawla YK. Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol 2012: 11: 478.
3. Tellez-Avila FI, Sanchez-Avila F, Garcia-Saenz-de-Sicilia M et al. Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis. World J Gastroenterol 2008: 14: 4771.
4. Motillo S, Filion KB, Genest J et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010: 56: 1113.
5. Pagdala M, Dasarathy S, Eghtesad B, McCullough AJ. Post transplant metabolic syndrome: an epidemic waiting to happen. Liver Transpl 2009: 15: 1662.
6. Watt KD. Metabolic syndrome: is immunosuppression to blame? Liver Transpl 2011: (Suppl 3): S38.
7. Misra A, Misra R, Wijesuriya M, Banerjee D. The metabolic syndrome in South Asians: continuing escalation & possible solutions. Indian J Med Res 2007: 125: 345.
8. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults-a population study using modified ATP III criteria. Diabetes Res Clin Pract 2003: 60: 199.
9. Tandon P, Ney M, Irwin I et al. Severe muscle depletion in patients on the liver transplant wait list-its prevalence and independent prognostic value. Liver Transpl 2012: 18: 1209.
10. Rantanen T, Harris T, Leveille SG et al. Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci 2000: 55A: M168.
11. Dominguez LJ, Barbagallo M. The cardiometabolic syndrome and sarcopenic obesity in older persons. J Cardiometab Syndr 2007: 2: 183.
12. Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol 2014: 20: 8061.
13. Schütz T, Hudjetz H, Roske AE et al. Weight gain in long-term survivors of kidney or liver transplantation-another paradigm of sarcopenic obesity? Nutrition 2012: 28: 378.
14. Nigam P, Misra A, Colles SL. Comparison of DEXA-derived body fat measurement to two race-specific bioelectrical impedance equations in healthy Indians. Diabetes Metab Syndr 2013: 7: 72.
15. Lucey MR, Terrault N, Ojo L et al. Long term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013: 19: 3.
16. Laish I, Braun M, Mor E, Sulkes J, Harif Y, Ben Ari Z. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl 2011: 17: 15.
17. Durrbach A. Diabetes after transplantation. Nephrol Ther 2006: 2(Suppl 3): S197.
18. Pageaux GP, Faure S, Bouyabrine H, Bismuth M, Assenat E. Long-term outcomes of liver transplantation: diabetes mellitus. Liver Transpl 2009: 15: S79.
19. Moss NG, Powell SL, Falk RJ. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci USA 1985: 82: 8222.
20. Everhart JE, Lombardero M, Lake JR, Wiesner RH, Zetterman RK, Hoofnagle JH. Weight change and obesity after liver transplantation. Incidence and risk factors. Liver Transpl Surg 1998: 4: 285.
21. Canzanello VJ, Schwartz L, Tater SJ, Textor SC, Wiesner RH, Porayko MK. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg 1997: 3: 1.
22. Seo S, Maganti K, Khehra M et al. De novo nonalcoholic fatty liver disease after liver transplantation. Liver Transpl 2007: 13: 844.
23. Hanouneh IA, Feldstein AE, McCullough AJ et al. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl 2008: 14: 1287.
24. Müller MJ, Lagerpusch M, Enderle J, Schautz B, Heller M, Bosy-Westphal A. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev 2012: 13(Suppl 2): 6.
25. Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity-definition, etiology and consequences. Curr Opin Clin Nutr Metab Care 2008: 11: 693.
26. Kim TN, Park MS, Lim KI et al. Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Res Clin Pract 2011: 93: 285.
27. Lim S, Kim JH, Yoon JW et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 2010: 33: 1652.
28. Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc 2014: 62: 253.
29. Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging 2009: 13: 460.
30. Dasarathy S. Posttransplant sarcopenia: an underrecognized early consequence of liver transplantation. Dig Dis Sci 2013: 58: 3103.
31. Wagner D, Adunka C, Kniepeiss D et al. Serum albumin, subjective global assessment, body mass index and the bioimpedance analysis in the assessment of malnutrition in patients up to 15 years after liver transplantation. Clin Transplant 2011: 25: E396.
32. Misra A, Chowbey P, Makkar BM et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India 2009: 57: 163.
33. Kushner RF, Gudivaka R, Schoeller DA. Clinical characteristics influencing bioelectrical impedance analysis measurements. Am J Clin Nutr 1996: 64(Suppl): S423.
34. Kyle U, Bosaeus I, Lorenzo A et al. Bioelectrical impedance analysis - part II: utilization in clinical practice. Clin Nutr 2004: 23: 1430.